Back to Results
First PageMeta Content



Sanofi Pasteur Dengue Latin America ENG
Add to Reading List

Document Date: 2015-04-07 03:44:13

Open Document

File Size: 177,16 KB

Share Result on Facebook

City

New York / Paris / New Orleans / Grosso do Sul / Lyon / /

Company

Genzyme / Sanofi / Sanofi Pasteur / Sanofi-Aventis / /

Continent

Asia / Americas / /

Country

Puerto Rico / Mexico / Honduras / Thailand / Colombia / Indonesia / France / Malaysia / United States / Brazil / Vietnam / Philippines / Singapore / /

Currency

EUR / /

Event

FDA Phase / Company Listing Change / /

IndustryTerm

healthcare / important tool / surveillance systems / therapeutic solutions / consumer healthcare / health care systems / health systems / vaccine solution / diabetes solutions / /

MedicalCondition

control dengue / severe dengue / next vaccine-preventable disease / Reported dengue / epidemics / infections / III dengue / dengue haemorrhagic fever / disease / vaccine preventable disease / Emerging Infectious Diseases / diabetes / dengue disease / infectious diseases / dengue / symptomatic virologically-confirmed dengue / mild non-specific illness / safe and effective dengue / respiratory distress / /

MedicalTreatment

vaccination / vaccinations / /

Organization

World Health Organization / Duke-NUS Graduate Medical School / American Society of Tropical Medicine and Hygiene / /

Person

Rivaldo Cunha / Successfully Completes / Olivier Charmeil / Duane Gubler / /

Position

candidate in development / principal investigator / global healthcare leader / leader / Chairman / Professor / President and Chief Executive Officer / Infectious Disease Specialist / Associate Professor / Candidate / /

Product

Latin America / Dengue Vaccine / /

ProvinceOrState

Louisiana / /

Region

Latin America / Caribbean / /

Technology

therapeutic solutions / /

URL

http /